A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis

PLoS One. 2014 Aug 5;9(8):e103329. doi: 10.1371/journal.pone.0103329. eCollection 2014.

Abstract

Objectives: Recent genome-wide association study found rs1801274, a functional single nucleotide polymorphism (SNP) in IgG receptor gene FCGR2A, was associated with increased risk of Kawasaki disease (KD). However, subsequent studies on the role of this SNP were limited and controversial.

Methods: A case-control study was conducted in a Chinese Han population including 428 KD patients and 493 controls to examine the association between rs1801274 and KD susceptibility. A meta-analysis was performed in combination with the relevant published studies to further clarify such an association.

Results: Our case-control study found that rs1801274 was significantly associated with increased risk of KD in the Chinese Han population, with an odds ratio (OR) of 1.58 (95% CI = 0.96-2.62) for the GA genotype and 1.93 (95% CI = 1.16-3.19) for the AA genotype compared with the GG genotype. The result of meta-analysis further demonstrated that the A allele of rs1801274 was significantly correlated with KD risk under the allelic model (OR = 1.35, 95% CI = 1.27-1.44) without heterogeneity by fixed-effects model analysis (Q = 17.30, p = 0.139). Moreover, sensitivity analysis supported the robustness of this meta-analysis.

Conclusion: These results further confirm that rs1801274 in the FCGR2A gene is significantly associated with increased risk of KD.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asian People / genetics
  • Biomarkers / metabolism
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Female
  • Gene Frequency
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Mucocutaneous Lymph Node Syndrome / epidemiology
  • Mucocutaneous Lymph Node Syndrome / genetics*
  • Polymorphism, Single Nucleotide*
  • Receptors, IgG / genetics*
  • Risk Factors

Substances

  • Biomarkers
  • FCGR2A protein, human
  • Receptors, IgG

Grants and funding

This work is supported, in part, by grants from The National Natural Science Foundation of China (81270177), Ministry of Health Research Foundation of China (201339378), The Health Bureau of Zhejiang Province (2009A124, 2009CA072), and population and family planning commission of Zhejiang province (JSW2013-A15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.